Xavier said that patients are often reluctant to quit smoking because they are fearful that they will gain weight. By adding ...

New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Cigna subsidiary Evernorth Health Services will authorize prior authorizations for GLP-1 weight-loss drugs under a new ...

The companies are allegedly selling "research grade" GLP-1 weight loss drugs that are not FDA-approved, and are selling the products without a pharmacy license.

KANSAS CITY, MISSOURI, US — Already on the path toward healthier, nutrient-dense products, the increasing popularity of GLP-1 ...

After adjusting for the weight loss benefits of surgery, GLP-1 drugs were linked to a 41% lower risk of obesity-related ...

Since being approved by the FDA in 2021, the drugs have become so popular that, at one point, supply couldn't keep up with the demand.

After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday.

Since being approved by the FDA in 2021, the drugs have become so popular that, at one point, supply couldn't keep up with the demand.

The FDA has approved medications like Zepbound and Wegovy for weight loss, which use the same active ingredient as the ...

SaveHealth explores the historical trajectory of weight loss drugs, examining their scientific basis, regulatory battles, public reception, and what lies ahead for pharmacotherapy in obesity ...